Veru Selects New Oral Enobosarm for Chronic Weight Loss
August 11, 2025
Veru Inc., a clinical-stage biopharmaceutical company focused on developing new treatments for cardiometabolic and inflammatory diseases, announced it has selected a new modified release oral